F M Investments LLC Raises Stake in Bath & Body Works, Inc. (NYSE:BBWI)

F M Investments LLC increased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 57.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 41,546 shares of the company's stock after purchasing an additional 15,151 shares during the quarter. F M Investments LLC's holdings in Bath & Body Works were worth $1,611,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC boosted its stake in shares of Bath & Body Works by 4.9% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock worth $271,000 after buying an additional 324 shares during the last quarter. SRS Capital Advisors Inc. lifted its holdings in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after acquiring an additional 329 shares during the period. TD Private Client Wealth LLC boosted its position in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock worth $54,000 after purchasing an additional 331 shares during the last quarter. UMB Bank n.a. grew its stake in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the period. Finally, Lindbrook Capital LLC increased its position in shares of Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Up 3.3 %

Shares of BBWI stock traded up $0.89 on Thursday, reaching $28.39. The company's stock had a trading volume of 1,582,690 shares, compared to its average volume of 4,703,766. The company has a market capitalization of $6.08 billion, a P/E ratio of 6.91, a PEG ratio of 0.92 and a beta of 1.69. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99. The stock's 50 day simple moving average is $32.43 and its 200-day simple moving average is $33.89.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.78 billion. Research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works declared that its board has approved a share buyback plan on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works's payout ratio is 21.98%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Piper Sandler raised shares of Bath & Body Works from a "neutral" rating to an "overweight" rating and cut their price target for the stock from $38.00 to $35.00 in a report on Wednesday, April 9th. Wells Fargo & Company upgraded shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Cowen restated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Raymond James reaffirmed an "outperform" rating and issued a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Finally, Barclays reduced their price objective on Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a report on Monday, March 3rd. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.69.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.